Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two-year suspension ...

The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...

“Whether consumers are using GLP-1 medications for weight management or are reducing sugar intake as part of their overall ...

(Reuters) -OPKO Health and Entera Bio are partnering to develop a once-daily pill for patients with obesity and other ...